EcoDrugPlus

24-Dehydrocholesterol Reductase

Ensembl ID : ENSEBUG00000012138
Gene Symbol: DHCR24
1 Cross references
209 Possible Orthologues:

3-Hydroxy-3-Methylglutaryl-Coa Reductase

Ensembl ID : ENSEBUG00000006021
Gene Symbol: HMGCR
1 Cross references
271 Possible Orthologues:

3-Phosphoinositide Dependent Protein Kinase 1

Ensembl ID : ENSEBUG00000005160
Gene Symbol: PDPK1
1 Cross references
245 Possible Orthologues:

4-Hydroxyphenylpyruvate Dioxygenase A

Ensembl ID : ENSEBUG00000011302
Gene Symbol: HPDA
1 Cross references
277 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a A

Ensembl ID : ENSEBUG00000007215
Gene Symbol: HTR1AA
1 Cross references
517 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 1a B

Ensembl ID : ENSEBUG00000004532
Gene Symbol: HTR1AB
1 Cross references
150 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 2b, G Protein-Coupled

Ensembl ID : ENSEBUG00000011623
Gene Symbol: HTR2B
1 Cross references
206 Possible Orthologues:

5-Hydroxytryptamine (Serotonin) Receptor 5a, Genome Duplicate A

Ensembl ID : ENSEBUG00000009747
Gene Symbol: HTR5AA
1 Cross references
299 Possible Orthologues:

5-Hydroxytryptamine Receptor 4

Ensembl ID : ENSEBUG00000016987
Gene Symbol: HTR4
1 Cross references
277 Possible Orthologues:

Adrm1 26s Proteasome Ubiquitin Receptor

Ensembl ID : ENSEBUG00000007819
Gene Symbol: ADRM1
1 Cross references
262 Possible Orthologues:

Akt Serine/threonine Kinase 1

Ensembl ID : ENSEBUG00000009622
Gene Symbol: AKT1
1 Cross references
221 Possible Orthologues:

Apex Nuclease (Multifunctional Dna Repair Enzyme) 1

Ensembl ID : ENSEBUG00000000622
Gene Symbol: APEX1
1 Cross references
214 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).